Reconstitution studies with alymphoid mice suggest that while recipients of wild-type ILC2s responded to suppressive activity of the agonist, recipients of the α7nAChR-deficient ILC2s did not show any alteration in AHR or eosinophilia after agonist treatment. The gene discussed is CHRNA7; the disease is Increased total eosinophil count.